Evusheld approved to prevent COVID-19 in people whose immune response is poor
People who have had a low immune response to the COVID-19 vaccine, including some patients with liver disease or liver cancer, may have access to a new prophylactic (intended to prevent disease) treatment. Evusheld (tixagevimab/cilgavimab), has today been authorised...
Significant reduction in deaths from hepatitis C in England, UK Health Security Agency reports
A new report issued today by the UK Health Security Agency has revealed that there has been considerable progress in eliminating hepatitis C as a public health problem in England, with deaths from the virus falling by 35% between 2015 and 2020. The number of people...
Research shows alcohol purchases for the heaviest drinkers increased by 17 times during lockdown
New research has found that Britain’s heaviest drinkers bought around 17 times more alcohol from shops and supermarkets than the lowest purchasing households during the lockdown period of March to July 2020. The data also demonstrates that households in socially...
Health leaders issue stark warning to Prime Minister: Don’t U-turn on children’s health
The British Liver Trust has joined leaders from the UK’s largest health charities and medical organisations today to issue a warning to the Prime Minister, urging him to not dilute new laws which could prevent thousands of children from developing overweight and...